Reshaping Australian drug policy: the dilemmas of generic medicines policy

Frederick J: Trading Blows, Target and Wal-mart Roll out $4 Generic Offers Nationwide. Drug News Store. 2006

Abbott T: Transcrip Press Conference: PBS Reform. 2006

Department of Health and Ageing: New Pricing and Listing Arrangements for Generic Medicines on the Pharmaceutical Benefits Scheme (PBS). [ http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-pbs-pricereductions/$FILE/qamar05.pdf ]

Davey P: Strategic Management: Pharmaceutical generics A Changing Playing Field. 4th Annual Pharma Marketing & Sales Congress, 3-4 May.

Genepharm Australasia: Annual Report 2006. [ http://www.genepharm.com.au/investors/news.php ]

Pharmaceutical Benefits Pricing Authority: Annual Report for the Year ended 30 June 2006. 2006, Canberra, Department of Health and Ageing

Lopez-Casanovas G, Puig-Junoy J: Review of the Literature on Reference Pricing. Health Policy. 2000, 54: 87-123. 10.1016/S0168-8510(00)00100-7.

Ioannides-Demos LL, Ibrahim JE, McNeil JJ: Reference-Based Pricing Schemes: Effect on Pharmaceutical Expenditure, Resource Utilisation and Health Outcomes. Pharmacoeconomics. 2002, 20: 577-591. 10.2165/00019053-200220090-00002.

Department of Health and Ageing: Questions and Answers: Price Change of Atorvastin (Lipitor) in the 1 August Issue of the Schedule of Pharmaceutical Benefits. [ http://www.health.gov.au/internet/wcms/publishing.nsf/Content/health-pbs-atorvastinqa# ]

Department of Health and Ageing: Strengthening Your PBS: Preparing for the Future. [ http://www.health.gov.au/internet/wcms/publishing.nsf/Content/Strengthening-your-PBS.htm ]

Hollis A: How Do Brands' "Own Generics" Affect Pharmaceutical Prices?. Review of Industrial Organization. 2005, 27: 329-350. 10.1007/s11151-005-5469-5.

Probyn A: Some Drugs More Equal Than Others: Pseudo-generics and Commercial Practice. Australian Health Review. 2004, 28: 207-217.

Thomas JR: Authorized Generic Pharmaceuticals: Effects on Innovation. [ http://digital.library.unt.edu/govdocs/crs//data/2006/upl-meta-crs-9508/RL33605_2006Aug08.pdf?PHPSESSID=66b9668fc6c02942c76df2dfdb8a8968 ]

Grattan M, Stafford A: US Drug Companies Eye Australia. The Age. 2006, Melbourne, , 2-

Faunce T, Doran E, Henry D, Drahos P, Pekarsky B, Neville W, Searles A: Assessing the Impact of the Australia-United States Free Trade Agreement on Australian and Global Medicines Policy. Globalization and Health. 2005, 1:

Metherell M: Patients to Receive a Sugar-Coated Pill. Sydney Morning Herald. 2006, Sydney, 1-

Mitchell A: Chemists Limit PBS Reform. Australian Financial Review. 2006, 58-